Skip to main content
. 2023 Oct 2;6(10):e2336604. doi: 10.1001/jamanetworkopen.2023.36604

Figure 3. Standardized Trend for Observed and Estimated 10-Year Overall Survival in Men With De Novo Metastatic Castration-Sensitive Prostate Cancer .

Figure 3.

Ten-year overall survival was estimated by use of a flexible parametric model standardized to baseline characteristics of men diagnosed in 2020. The 10-year restricted mean survival (RMS) was used to report the increase in survival time. Dashed lines represent lower and upper limits of the 95% CIs.